Evaluation of hormone receptor, human epidermal growth factor receptor‐2 and K i‐67 with core needle biopsy and neoadjuvant chemotherapy effects in breast cancer patients

Abstract Background We investigated the reliability of core needle biopsy ( CNB ) in evaluating the status of hormone receptor ( HR ), human epidermal growth factor receptor ( HER) ‐2, and K i‐67 status, and the effect of neoadjuvant chemotherapy ( NAC ) on the expression of these immunohistochemica...

Full description

Saved in:
Bibliographic Details
Published inThoracic cancer Vol. 6; no. 1; pp. 64 - 69
Main Authors Ge, Wen‐kai, Yang, Ben, Zuo, Wen‐shu, Zheng, Gang, Dai, Ying‐qi, Han, Chao, Yang, Li, Zheng, Mei‐zhu
Format Journal Article
LanguageEnglish
Published 01.01.2015
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Background We investigated the reliability of core needle biopsy ( CNB ) in evaluating the status of hormone receptor ( HR ), human epidermal growth factor receptor ( HER) ‐2, and K i‐67 status, and the effect of neoadjuvant chemotherapy ( NAC ) on the expression of these immunohistochemical markers. Methods Among 177 patients with breast adenocarcinoma, 95 patients underwent NAC and the remaining 82 patients made up the control group. Immunohistochemistry ( IHC ) was used to evaluate the expression status of estrogen receptor ( ER ), progesterone receptor ( PR ), HER ‐2, and K i‐67 in the specimens obtained by surgical excision or CNB . Results I n the control group, the expression of ER , PR , HER ‐2, and K i‐67 was highly consistent between samples from surgical excision or CNB (all r > 0.8, P < 0.05). In the NAC group, the proportions of samples with changes in ER , PR , HER ‐2, and K i‐67 expression were 12.7%, 24.1%, 5.1%, and 38.0%, respectively; the figures in the control group were 2.4%, 4.9%, 2.4%, and 7.3%, respectively, which significantly differed in ER , PR , and K i‐67 ( P < 0.05), but not HER ‐2 ( P > 0.05). In the NAC group, pre‐ and post‐treatment ER + rates did not significantly differ ( P > 0.05), although PR + and high K i‐67 expression rates did significantly differ ( P < 0.05). Conclusion Neither CNB nor surgical excision samples gave highly consistent results in HR , HER ‐2, and K i‐67 status. NAC can alter HR and K i‐67 status in breast adenocarcinoma patients. NAC decreased PR + rate and K i‐67 expression. The mean ER + rate exhibited a decreasing, but insignificant trend after NAC treatment. NAC had no significant effect on HER ‐2 expression.
ISSN:1759-7706
1759-7714
DOI:10.1111/1759-7714.12133